Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec;12(1):3125-3136.
doi: 10.1080/21505594.2021.2014681.

Seneca Valley virus 3Cpro degrades heterogeneous nuclear ribonucleoprotein A1 to facilitate viral replication

Affiliations

Seneca Valley virus 3Cpro degrades heterogeneous nuclear ribonucleoprotein A1 to facilitate viral replication

Jiangwei Song et al. Virulence. 2021 Dec.

Abstract

Seneca Valley virus (SVV) is a recently-identified important pathogen that is closely related to idiopathic vesicular disease in swine. Infection of SVV has been shown to induce a variety of cellular factors and their activations are essential for viral replication, but whether heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) involved in SVV replication is unknown. The cytoplasmic redistribution of hnRNP A1 is considered to play an important role in the virus life cycle. Here, we demonstrated that SVV infection can promote redistribution of the nucleocytoplasmic shuttling RNA-binding protein hnRNP A1 to the cytoplasm from the nucleus, whereas hnRNP A1 remained mainly in the nucleus of mock-infected cells. siRNA-mediated knockdown of the gene encoding hnRNP A1 attenuated viral replication as evidenced by decreased viral protein expression and virus production, whereas its overexpression enhanced replication. Moreover, infection with SVV induced the degradation of hnRNP A1, and viral 3 C protease (3 Cpro) was found to be responsible for its degradation and translocation. Further studies demonstrated that 3 Cpro induced hnRNP A1 degradation through its protease activity, via the proteasome pathway. This degradation could be attenuated by a proteasome inhibitor (MG132) and inactivation of the conserved catalytic box in 3 Cpro. Taken together, these results presented here reveal that SVV 3 C protease targets cellular hnRNP A1 for its degradation and translocation, which is utilized by SVV to aid viral replication, thereby highlighting the control potential of strategies for infection of SVV.

Keywords: 3C protease; Seneca valley virus (SVV); degradation; hnRNP A1; replication.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Figures

Figure 1.
Figure 1.
SVV infection induces hnRNP A1 degradation. (a, d) BHK-21cells and PK-15 cells after SVV infection were collected at 0, 3, 6, 9, and 12 hpi, and 0, 12, and 24 hpi, respectively. The levels of cellular hnRNP A1 were analyzed by Western blotting. (b, e) The expression of cellular hnRNP A1 normalized against β-actin. (c, f) BHK-21 and PK-15 cells were infected with SVV, respectively. Infected cells were harvested, and the transcriptional levels of hnRNP A1 were calculated by qRT-PCR. Expression of hnRNP A1 was normalized to the actin mRNA level. GraphPad Prism was used for statistical analysis. The data are represented as the mean ± SD from three independent experiments (*P < 0.05; **P < 0.01; ***P < 0.001; NS, not significant)
Figure 2.
Figure 2.
SVV infection induces translocation of hnRNP A1 to the cytoplasm from the nucleus. (a) At 12 h after SVV infection, the cultured BHK-21 cells were stained with hnRNP A1 antibody (red), SVV VP1 antibody (green), and DAPI (blue), then examined by confocal microscopy. (b) Statistical analysis for the percentage redistribution of hnRNP A1 after SVV infection. GraphPad Prism was used for statistical analysis, and the data was expressed as mean ± SD from three independent experiments. (***P < 0.001). (c) At 6 h after SVV infection, the cultured BHK-21 cells were stained with the hnRNP A1 antibody (green), SVV VP1 antibody (green), dsRNA antibody (red), and DAPI (blue), then examined by confocal microscopy. (d) Cell cytoplasmic and nuclear components were extracted from SVV-infected cells. Samples were detected by Western blotting with antibodies against hnRNP A1, VP1, histone H3, and β-actin. (e) The relative gray intensity of cytoplasmic hnRNP A1 was normalized against total hnRNP A1 and quantified by ImageJ; GraphPad Prism was used for statistical analysis, and the data was expressed as mean ±SD from three independent experiments. (***P < 0.001)
Figure 3.
Figure 3.
SVV 3C was responsible for hnRNP A1 degradation and translocation. (a) Western blot analysis of BHK-21 cells cotransfected with GFP-tagged SVV protein-expressing plasmids and HA-hnRNP A1. (b) Rations to β-actin of three independent experiments (*P < 0.05; ***P < 0.001). Image J was employed to quantify the protein levels. (c) Fluorescence for transfection of plasmids expressing GFP (green) and GFP-3C(green), endogenous hnRNP A1 (red) was stained with the hnRNP A1 antibody, and DAPI (blue) in BHK-21 cells, and then examined by confocal microscopy. (d) Fluorescence to analyze transfection of plasmids expressing GFP (green), GFP-3C (green), and HA hnRNP A1 were stained with the HA-tagged antibody (red), and DAPI (blue) in BHK-21 cells, and then examined by confocal microscope
Figure 4.
Figure 4.
Enzyme activity of 3C was essential for hnRNP A1 degradation. (a) BHK-21 cells were cotransfected with HA-hnRNP A (1 μg) and an increasing amount of GFP-3C (0.1, 1, 2 μg) or empty vector (1 μg), respectively. The cell lysates were analyzed at 24 h post-transfection using Western blot. (b) The ratios to β-actin of three independent experiments of (A) (*P < 0.05; ***P < 0.001). Image J was employed to quantify the protein levels. (c) BHK-21 cells were transfected for 24 h with GFP-3C-WT, GFP-3C-H48A, GFP-3C-C160A, GFP-3C-DM, or empty vector, respectively. The cell lysates were analyzed at 24 h post-transfection using Western blot. (d) The ratios to β-actin of three independent experiments of (C) (*P < 0.05; ***P < 0.001). Image J was employed to quantify the protein levels. (e) The viability of BHK-21 cells after treatment with chemical reagents was tested by CCK-8 assay (NS, not significant). (f) BHK-21 cells were cotransfected with HA-hnRNP A1 and GFP-3C or empty vector, respectively. Cells were treated with DMSO, Z-VAD-FMK (50 μM), MG132 (10 μM), and NH4Cl (10 mM). The cell lysates were analyzed at 24 h post-transfection using Western blot. (g) The ratios to β-actin of three independent experiments of (F) (***P < 0.001). Image J was employed to quantify the protein levels
Figure 5.
Figure 5.
Downregulation of the expression of hnRNP A1 inhibits SVV replication in BHK-21 cells. (a) The silencing efficiency of hnRNP A1 in BHK-21 cells was measured by Western blot at 48 h after siRNA transfection at a concentration of 20 pM, and with no siRNA transfection. (b) The viability of siRNA-transfected BHK-21 cells and normal BHK-21 cells, tested using the CCK-8 assay (NS, not significant). The viability was analyzed using GraphPad Prism, and data were represented as the mean ± SD of three independent experiments (NS, no significant). (c) Western blotting analyzes the levels of VP1 protein and hnRNP A1 in siRNA-transfected BHK-21 cells after SVV infection. (d) The relative gray intensity for VP1 normalized against β-actin was quantified using ImageJ. The results are reported as the mean ± SD of three independent experiments (***P < 0.001; NS, not significant). (e) siRNA transfected and non-siRNA transfected BHK-21 cells were infected with SVV; viral titers in the supernatants at 6 and 12 h post-infection were determined by TCID50 assay. The virus titer was examined using GraphPad Prism, and data were reported as mean ± SD (***P < 0.001; NS, not significant)
Figure 6.
Figure 6.
Ectopic expression of hnRNP A1 enhanced SVV replication in BHK-21 cells. (a) Fluorescence of rescued lentiviruses in HEK-293 FT transfected cells and lentivirus-transduced BHK-21 cells expressing hnRNP A1-GFP and GFP. (b) Cell viability was examined by CCK-8 assay in lentiviruses-transduced BHK-21 cells (NS, not significant). (c) Viral titers (tested by TCID50 assay) in the supernatants of SVV infected cells after 6 and 12 hpi (*P < 0.05; **P < 0.01; NS, not significant). (d) Western blot analysis of VP1, hnRNP A1-GFP, GFP, and β-actin in lysates collected from SVV-infected cells at 0, 6, and 12 h post-infection, and using anti-VP1 and anti-GFP antibodies. (e) The relative gray intensity for VP1 normalized against β-actin was quantified using ImageJ. The results are reported as the mean ± SD from three independent experiments. (***P < 0.001; NS, not significant)

Similar articles

Cited by

References

    1. Leme RA, Alfieri AF, Alfieri AA.. Update on Senecavirus infection in pigs. Viruses. 2017;9(7):170. - PMC - PubMed
    1. Hales LM, Knowles NJ, Reddy PS, et al. Complete genome sequence analysis of Seneca Valley virus-001, a novel oncolytic picornavirus. J Gen Virol. 2008;89(Pt 5):1265–1275. - PubMed
    1. Pasma T, Davidson S, Shaw SL.. Idiopathic vesicular disease in swine in Manitoba. Can Vet J. 2008;49(1):84–85. - PMC - PubMed
    1. Reddy PS, Burroughs KD, Hales LM, et al. Seneca Valley virus, a systemically deliverable oncolytic picornavirus, and the treatment of neuroendocrine cancers. J Natl Cancer Inst. 2007;99(21):1623–1633. - PMC - PubMed
    1. Venkataraman S, Reddy SP, Loo J, et al. Structure of Seneca Valley virus-001: an oncolytic picornavirus representing a new genus. Structure. 2008;16(10):1555–1561. - PMC - PubMed

Publication types

MeSH terms

Substances

Supplementary concepts

Grants and funding

This work was supported by the Special Program on Science and Technology Innovation Capacity Building of Beijing Academy of Agriculture and Forestry Sciences (BAAFS) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).

LinkOut - more resources